Healthcare - Biotechnology - NASDAQ - US
$ 63.42
-3.32 %
$ 12.1 B
Market Cap
38.91
P/E
BALANCE SHEET
6.84 B
ASSETS
1.89 B
LIABILITIES
4.95 B
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
BioMarin Pharmaceutical Inc.
| Current Assets | 2.96 B |
| Cash & Short-Term Investments | 1.07 B |
| Receivables | 634 M |
| Other Current Assets | 1.25 B |
| Non-Current Assets | 3.89 B |
| Long-Term Investments | 611 M |
| PP&E | 1.11 B |
| Other Non-Current Assets | 2.16 B |
| Current Liabilities | 1.18 B |
| Accounts Payable | 316 M |
| Short-Term Debt | 503 M |
| Other Current Liabilities | 359 M |
| Non-Current Liabilities | 713 M |
| Long-Term Debt | 593 M |
| Other Non-Current Liabilities | 120 M |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | Dec-2013 | Dec-2012 | Dec-2011 | Dec-2010 | Dec-2009 | Dec-2008 | Dec-2007 | Dec-2006 | Dec-2005 | Dec-2004 | Dec-2003 | Dec-2002 | Dec-2001 | Dec-2000 | Dec-1999 | Dec-1998 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||||||||
| Cash & Cash Equivalents | 755.1 | 724.5 | 587.3 | 649.2 | 437.4 | 494.0 | 598.0 | 408.3 | 397.0 | 875.5 | 568.8 | 180.5 | 46.3 | 88.1 | 167.2 | 222.9 | 228.3 | 89.2 | 38.1 | 13.1 | 121.4 | 33.6 | 12.5 | 16.5 | 23.4 | 9.4 |
| Short Term Investments | 318.7 | 567.0 | 426.6 | 416.2 | 316.4 | 590.3 | 797.9 | 381.3 | 195.6 | 69.7 | 215.9 | 270.2 | 148.8 | 186.0 | 133.5 | 336.9 | 357.3 | 199.7 | 9.7 | 35.7 | 85.0 | 40.3 | 118.6 | 23.7 | 39.6 | 0 |
| Receivables | 633.7 | 461.3 | 373.4 | 448.4 | 377.4 | 342.6 | 261.4 | 215.3 | 165.0 | 144.5 | 117.8 | 109.1 | 115.6 | 95.1 | 80.6 | 54.3 | 17.0 | 14.7 | 6.9 | 4.0 | 0 | 0 | 3.1 | 2.9 | 2.5 | 0.7 |
| Inventory | 1 107.2 | 894.1 | 776.7 | 698.5 | 680.3 | 530.9 | 475.8 | 355.1 | 271.7 | 199.5 | 162.6 | 128.7 | 130.1 | 109.7 | 78.7 | 73.2 | 32.4 | 25.1 | 10.9 | 2.3 | 0 | 0 | 0 | 0.4 | 0.7 | 100 K |
| Other Current Assets | 141.4 | 104.5 | 110.4 | 129.9 | 130.7 | 98.4 | 74.0 | 61.7 | 60.4 | 140.7 | 60.8 | 55.0 | 29.0 | 25.3 | 7.8 | 50.4 | 9.3 | 5.6 | 3.3 | 30.1 | 18.9 | 7.1 | 2.6 | 1.0 | 0.3 | 2.6 |
| Total Current Assets | 2 956.1 | 2 751.5 | 2 274.4 | 2 342.2 | 1 942.1 | 2 056.2 | 2 207.1 | 1 421.8 | 1 089.6 | 1 425.6 | 1 137.4 | 743.5 | 469.8 | 504.3 | 467.7 | 737.7 | 644.3 | 334.2 | 68.9 | 85.3 | 225.3 | 81.1 | 136.8 | 44.5 | 66.4 | 12.8 |
| PP&E | 1 112.2 | 1 073.4 | 1 035.5 | 1 032.5 | 1 010.9 | 948.7 | 896.7 | 798.8 | 704.2 | 523.5 | 319.3 | 284.5 | 269.0 | 221.9 | 199.1 | 125.0 | 76.8 | 55.5 | 37.3 | 42.5 | 25.2 | 28.2 | 32.6 | 20.7 | 25.1 | 6.2 |
| Intangible Assets | 294.7 | 338.6 | 388.7 | 417.3 | 456.6 | 491.8 | 517.5 | 553.8 | 684.0 | 156.6 | 163.1 | 163.0 | 180.3 | 103.6 | 41.0 | 7.6 | 9.6 | 11.7 | 36.6 | 61.5 | 0 | 0 | 0 | 9.9 | 11.5 | 11.7 |
| Goodwill | 196.2 | 196.2 | 196.2 | 196.2 | 197.0 | 197.0 | 197.0 | 197.0 | 197.0 | 54.3 | 54.3 | 51.5 | 51.5 | 53.4 | 23.7 | 21.3 | 21.3 | 21.3 | 21.3 | 45.1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 611.1 | 333.8 | 507.8 | 285.5 | 412.0 | 235.9 | 385.8 | 572.7 | 425.7 | 98.9 | 281.5 | 117.1 | 94.9 | 129.3 | 170.3 | 2.5 | 45.0 | 31.0 | 32.0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Long Term Assets | 125.5 | 176.2 | 151.8 | 142.2 | 122.0 | 36.6 | 29.9 | 32.8 | 408.6 | 65.3 | 143.2 | 16.6 | 15.5 | 14.2 | 15.3 | 12.6 | 63.3 | 40.8 | 52.5 | 43.7 | 5.9 | 1.3 | 2.5 | 1.8 | 0.6 | 0.8 |
| Other Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 6 841.6 | 6 375.1 | 6 003.3 | 5 848.0 | 4 690.0 | 4 427.1 | 4 633.1 | 4 023.7 | 3 729.4 | 2 490.5 | 2 249.2 | 1 601.6 | 1 303.7 | 1 262.6 | 917.2 | 906.7 | 815.3 | 463.4 | 195.3 | 233.0 | 256.3 | 110.6 | 171.8 | 76.9 | 103.5 | 31.5 |
| LIABILITIES | ||||||||||||||||||||||||||
| Accounts Payable | 315.5 | 231.2 | 193.0 | 191.4 | 241.0 | 207.6 | 166.6 | 191.4 | 179.3 | 3.4 | 95.3 | 67.1 | 12.2 | 5.0 | 7.6 | 58.9 | 1.2 | 2.3 | 0.5 | 14.6 | 10.1 | 3.9 | 4.3 | 4.7 | 3.1 | 1.4 |
| Short Term Debt | 502.7 | 10.4 | 10.5 | 11.8 | 372.6 | 0 | 360.9 | 22.5 | 0 | 0 | 0 | 23.4 | 0 | 0 | 0 | 70.7 | 6.3 | 6.8 | 3.9 | 3.7 | 0 | 0 | 1.6 | 27 K | 26 K | 0 |
| Other Current Liabilities | 351.6 | 330.3 | 326.3 | 270.0 | 297.5 | 307.8 | 273.7 | 217.6 | 200.2 | 226.9 | 84.4 | 77.8 | 78.0 | 75.2 | 70.5 | 0.2 | 48.7 | 29.9 | 36.0 | 51.8 | 2.7 | 2.9 | 2.4 | 2.1 | 2.0 | 0.6 |
| Total Current Liabilities | 1 177.0 | 588.9 | 539.8 | 492.5 | 932.5 | 523.2 | 816.5 | 439.3 | 445.5 | 235.7 | 183.3 | 170.4 | 94.1 | 83.8 | 78.2 | 130.1 | 61.5 | 46.0 | 40.4 | 70.1 | 12.8 | 6.8 | 8.3 | 6.9 | 5.1 | 2.0 |
| Long Term Debt | 593.1 | 1 083.0 | 1 112.9 | 1 075.1 | 486.2 | 830.4 | 813.5 | 660.8 | 662.3 | 658.0 | 655.6 | 324.9 | 346.3 | 377.5 | 497.1 | 497.1 | 497.4 | 223.9 | 142.0 | 141.4 | 125.0 | 0 | 4.0 | 56 K | 85 K | 100 K |
| Deferred Tax Income | 0 | 0 | 0 | 0 | 0 | 62.1 | 44.3 | 0 | 143.5 | 166.3 | 150.4 | 33.3 | 35.1 | 36.5 | 0 | 0 | 0 | (5.0) | (11.8) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 119.9 | 100.0 | 79.8 | 174.3 | 148.9 | 105.5 | 194.4 | 157.3 | 77.3 | 68.8 | 69.3 | 57.3 | 50.1 | 46.5 | 19.7 | 2.9 | 68.6 | 69.4 | 76.6 | 89.5 | 0.7 | 5.2 | 0 | 0 | 0 | 0 |
| Total Liabilities | 1 890.1 | 1 771.9 | 1 732.6 | 1 742.0 | 1 567.7 | 1 459.2 | 1 824.5 | 1 257.4 | 1 328.5 | 962.6 | 908.2 | 585.9 | 530.6 | 545.4 | 595.0 | 630.0 | 627.6 | 345.6 | 272.8 | 300.9 | 138.5 | 12.1 | 12.3 | 6.9 | 5.2 | 2.1 |
| EQUITY | ||||||||||||||||||||||||||
| Common Stock | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 100 K | 97 K | 92 K | 75 K | 65 K | 64 K | 54 K | 52 K | 37 K | 35 K | 0 |
| Retained Earnings | (621.6) | (789.2) | (925.7) | (861.6) | (1 720.7) | (1 694.1) | (1 637.5) | (1 520.5) | (1 021.6) | (849.8) | (715.8) | (539.4) | (425.1) | (371.3) | (577.1) | (576.6) | (607.4) | (591.6) | (563.1) | (488.8) | (301.4) | (225.6) | (148.1) | (80.5) | (43.1) | (15.1) |
| Other Accumulative Comprehensive Income/Loss | (38.6) | (3.9) | 14.4 | (16.1) | 20.2 | 5.3 | (23.0) | 12.8 | 21.0 | 27.5 | 5.0 | (0.2) | 4.9 | 0.2 | 0.9 | 1.1 | 0.1 | 25 K | 16 K | (0.4) | 5.1 | 5.0 | 2.4 | (3.5) | (5.1) | (0.3) |
| Total Equity | 4 951.5 | 4 603.2 | 4 270.7 | 4 106.0 | 3 122.4 | 2 967.9 | 2 808.7 | 2 766.3 | 2 400.8 | 1 527.9 | 1 341.0 | 1 015.8 | 773.0 | 717.3 | 322.2 | 276.7 | 187.7 | 117.8 | (77.5) | (68.0) | 117.9 | 98.5 | 159.5 | 70.0 | 98.4 | 29.4 |
| Total Liabilities and Equity | 6 841.6 | 6 375.1 | 6 003.3 | 5 848.0 | 4 690.0 | 4 427.1 | 4 633.1 | 4 023.7 | 3 729.4 | 2 490.5 | 2 249.2 | 1 601.6 | 1 303.7 | 1 262.6 | 917.2 | 906.7 | 815.3 | 463.4 | 195.3 | 233.0 | 256.3 | 110.6 | 171.8 | 76.9 | 103.5 | 31.5 |
| SHARES OUTSTANDING | ||||||||||||||||||||||||||
| Common Shares Outstanding | 187.8 | 185.3 | 182.9 | 180.8 | 179.0 | 177.1 | 174.4 | 166.0 | 160.0 | 145.6 | 137.8 | 120.3 | 112.1 | 103.1 | 100.3 | 99.0 | 95.9 | 84.6 | 68.8 | 64.4 | 62.1 | 53.3 | 41.1 | 35.9 | 29.9 | 22.5 |